drugset / Trial / NCT00576537

Tumor Lysate Pulsed Dendritic Cell Immunotherapy for Patients With Brain Tumors

NCT00576537

Phase 2 Completed 50 enrolled Cedars-Sinai Medical Center
NaSingle-groupOpen-labelTreatment

Summary

This research is being determine whether vaccinations with your own immune cells called " dendritic cells " can activate your immune system to fight your brain tumor.

Timeline

Start
2001-03
Primary completion
2011-10
Completion
2011-10

Drugs

EvaluationDrugModalityDoseRoute
Subject DCVax-L Vaccine

Indications